Indaptus Therapeutics, Inc. Common Stock
Symbol: INDP (NASDAQ)
7.22
▼ (-7.62%) -0.595
Company Description:
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
Key Stats
- Today's Open: $7.745
- Today's High: $8.357
- Today's Low: $7.215
- Today's Volume: 6.42K
- Yesterday Close: $7.81
- Yesterday High: $8.29
- Yesterday Low: $7.4
- Yesterday Volume: 6.53K
- Last Min Volume: 9
- Last Min High: $7.215
- Last Min Low: $7.215
- Last Min VWAP: $7.215
Company Profile
- Name: Indaptus Therapeutics, Inc. Common Stock
- Website: https://www.indaptusrx.com
- Listed Date: 2021-08-04
- Location: NEW YORK, NY
- Market Status: Active
- CIK Number: 0001857044
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $7.96M
- Round Lot: 100
- Outstanding Shares: 1.12M
- Asset Type: CS
RECENT FILINGS FOR INDP
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-13 | S-3 | View |
| 2025-08-13 | S-3 | View |
| 2025-08-13 | 10-Q | View |
| 2025-08-13 | 8-K | View |
| 2025-07-29 | 4 | View |
| 2025-07-29 | 8-K | View |
| 2025-07-16 | 8-K | View |
| 2025-07-01 | 8-K | View |
| 2025-06-26 | 8-K | View |
| 2025-06-23 | DEF 14A | View |
| 2025-06-20 | D | View |
| 2025-06-13 | PRE 14A | View |
| 2025-06-13 | 8-K | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | 8-K | View |
Latest News on INDP